Hiv Aids Diagnostics Market

HIV/AIDS Diagnostics Market (Product - Kits and Reagents and Instruments; Test Type - Rapid Tests (POC), ELISA, and Nucleic Acid Tests; End User - Hospitals, Private Diagnostic Laboratories, and Academic and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL26582
  • Published On : Jul 2017
  • No. of Pages : 167
  • Category : Healthcare

1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights
 
2. Assumptions and Research Methodology
 
3. Executive Summary: Global HIV/AIDS Diagnostics Market
 
4. Market Overview
      4.1. Introduction
             4.1.1. Product Definition
             4.1.2. Industry Evolution / Developments
      4.2. Market Dynamics
             4.2.1. Drivers
                           4.2.1.1. Economic Drivers
                           4.2.1.2. Supply Side Drivers
                           4.2.1.3. Demand Side Drivers
             4.2.2. Restraints
             4.2.3. Opportunities
             4.2.4. Key Trends
 
5. Global HIV/AIDS Diagnostics Market Analysis and Forecast, 2017-2025
      5.1. Market Revenue Projections (US$ Mn)
      5.2. Porter’s Five forces Analysis: Global HIV/AIDS Diagnostics Market
      5.3. Recent Development (Industry Updates, Merger & Acquisition) 
      5.4. Global HIV/AIDS Epidemiology
      5.5. Disease Overview
      5.6. Preventive Measures for HIV/AIDS
      5.7. Future Market Outlook
 
6. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By Product Type
      6.1. Introduction & Definition
      6.2. Key Findings / Developments
      6.3. Market Value (US$ Mn) Forecast By Product Type
             6.3.1. Kits and Reagents
             6.3.2. Instruments
             6.3.3. Others
      6.4. Market Attractiveness by Product Type
 
7. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By Test Type
      7.1. Introduction & Definition
      7.2. Key Findings / Developments
      7.3. Market Value (US$ Mn) Forecast By Test Type
             7.3.1. Rapid Tests (POC)
             7.3.2. ELISA
             7.3.3. Nucleic Acid Tests
             7.3.4. Others 
      7.4. Market Attractiveness by Test Type
 
8. Global HIV/AIDS Diagnostics Market Analysis and Forecast, By End User
      8.1. Introduction & Definition
      8.2. Key Findings / Developments
      8.3. Market Value (US$ Mn) Forecast By End User
             8.3.1. Hospitals and Clinics
             8.3.2. Private Diagnostic Laboratories
             8.3.3. Academic and Research Institutes
             8.3.4. Others 
      8.4. Market Attractiveness by End User
 
9. Global HIV/AIDS Diagnostics Market Analysis and Forecasts, By Region
      9.1. Key Findings
      9.2. Market Value (US$ Mn) Forecast By Region
             9.2.1. North America
             9.2.2. Europe
             9.2.3. Asia Pacific
             9.2.4. Latin America
             9.2.5. Middle East and Africa
      9.3. Market Attractiveness by Region
 
10. North America HIV/AIDS Diagnostics Market Analysis and Forecast
      10.1. Key Findings
      10.2. Market Value (US$ Mn) Forecast By Country
             10.2.1. U.S.
             10.2.2. Canada
      10.3. Market Value (US$ Mn) Forecast By Product Type
             10.3.1. Kits and Reagents
             10.3.2. Instruments
             10.3.3. Others
      10.4. Market Value (US$ Mn) Forecast By Test Type
             10.4.1. Rapid Tests (POC)
             10.4.2. ELISA
             10.4.3. Nucleic Acid Tests
             10.4.4. Others 
      10.5. Market Value (US$ Mn) Forecast By End User
             10.5.1. Hospitals and Clinics
             10.5.2. Private Diagnostic Laboratories
             10.5.3. Academic and Research Institutes
             10.5.4. Others 
      10.6. Market Attractiveness Analysis 
             10.6.1. By Country
             10.6.2. By Product Type
             10.6.3. By Test Type
             10.6.4. By End User
 
11. Europe HIV/AIDS Diagnostics Market Analysis and Forecast
      11.1. Key Findings
      11.2. Market Value (US$ Mn) Forecast By Country
             11.2.1. Germany
             11.2.2. U.K.
             11.2.3. France
             11.2.4. Spain
             11.2.5. Italy
             11.2.6. Rest of Europe
      11.3. Market Value (US$ Mn) Forecast By Product Type
             11.3.1. Kits and Reagents
             11.3.2. Instruments
             11.3.3. Others
      11.4. Market Value (US$ Mn) Forecast By Test Type
             11.4.1. Rapid Tests (POC)
             11.4.2. ELISA
             11.4.3. Nucleic Acid Tests
             11.4.4. Others 
      11.5. Market Value (US$ Mn) Forecast By End User
             11.5.1. Hospitals and Clinics
             11.5.2. Private Diagnostic Laboratories
             11.5.3. Academic and Research Institutes
             11.5.4. Others 
      11.6. Market Attractiveness Analysis 
             11.6.1. By Country
             11.6.2. By Product Type
             11.6.3. By Test Type
             11.6.4. By End User
 
12. Asia Pacific HIV/AIDS Diagnostics Market Analysis and Forecast
      12.1. Key Findings
      12.2. Market Value (US$ Mn) Forecast By Country
             12.2.1. China
             12.2.2. Japan
             12.2.3. India
             12.2.4. Australia & New Zealand
             12.2.5. Rest of Asia Pacific
      12.3. Market Value (US$ Mn) Forecast By Product Type
             12.3.1. Kits and Reagents
             12.3.2. Instruments
             12.3.3. Others
      12.4. Market Value (US$ Mn) Forecast By Test Type
             12.4.1. Rapid Tests (POC)
             12.4.2. ELISA
             12.4.3. Nucleic Acid Tests
             12.4.4. Others 
      12.5. Market Value (US$ Mn) Forecast By End User
             12.5.2. Private Diagnostic Laboratories
             12.5.3. Academic and Research Institutes
             12.5.4. Others 
      12.6. Market Attractiveness Analysis 
             12.6.1. By Country
             12.6.2. By Product Type
             12.6.3. By Test Type
             12.6.4. By End User
 
13. Latin America HIV/AIDS Diagnostics Market Analysis and Forecast
      13.1. Key Findings
      13.2. Market Value (US$ Mn) Forecast By Country
             13.2.1. Brazil
             13.2.2. Mexico
             13.2.3. Rest of Latin America
      13.3. Market Value (US$ Mn) Forecast By Product Type
             13.3.1. Kits and Reagents
             13.3.2. Instruments
             13.3.3. Others
      13.4. Market Value (US$ Mn) Forecast By Test Type
             13.4.1. Rapid Tests (POC)
             13.4.2. ELISA
             13.4.3. Nucleic Acid Tests
             13.4.4. Others 
      13.5. Market Value (US$ Mn) Forecast By End User
             13.5.1. Hospitals and Clinics
             13.5.2. Private Diagnostic Laboratories
             13.5.3. Academic and Research Institutes
             13.5.4. Others 
      13.6. Market Attractiveness Analysis 
             13.6.1. By Country
             13.6.2. By Product Type
             13.6.3. By Test Type
             13.6.4. By End User
 
14. Middle East and Africa HIV/AIDS Diagnostics Market Analysis and Forecast
      14.1. Key Findings
      14.2. Market Value (US$ Mn) Forecast By Country
             14.2.1. Saudi Arabia
             14.2.2. South Africa
             14.2.3. Rest of MEA
      14.3. Market Value (US$ Mn) Forecast By Product Type
             14.3.1. Kits and Reagents
             14.3.2. Instruments
             14.3.3. Others
      14.4. Market Value (US$ Mn) Forecast By Test Type
             14.4.1. Rapid Tests (POC)
             14.4.2. ELISA
             14.4.3. Nucleic Acid Tests
             14.4.4. Others 
      14.5. Market Value (US$ Mn) Forecast By End User
             14.5.1. Hospitals and Clinics
             14.5.2. Private Diagnostic Laboratories
             14.5.3. Academic and Research Institutes
             14.5.4. Others 
      14.6. Market Attractiveness Analysis 
             14.6.1. By Country
             14.6.2. By Product Type
             14.6.3. By Test Type
             14.6.4. By End User
 
15. Competition Landscape
      15.1. Market Player- Competition Matrix
      15.2. Market Share Analysis by Company (2016)
      15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
             15.3.1. F. Hoffmann-La Roche Ltd. 
                       15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.1.2 Product Portfolio
                       15.3.1.3 SWOT Analysis
                       15.3.1.4 Financial Overview
                       15.3.1.5 Strategic Overview
             15.3.2. Hologic, Inc. 
                       15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.2.2 Product Portfolio
                       15.3.2.3 SWOT Analysis
                       15.3.2.4 Financial Overview
                       15.3.2.5 Strategic Overview
             15.3.3. Alere, Inc.
                       15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.3.2 Product Portfolio
                       15.3.3.3 SWOT Analysis
                       15.3.3.4 Financial Overview
                       15.3.3.5 Strategic Overview
             15.3.4. Bio-Rad Laboratories
                       15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.4.2 Product Portfolio
                       15.3.4.3 SWOT Analysis
                       15.3.4.4 Financial Overview
                       15.3.4.5 Strategic Overview
             15.3.5. Abbott Laboratories 
                       15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.5.2 Product Portfolio
                       15.3.5.3 SWOT Analysis
                       15.3.5.4 Financial Overview
                       15.3.5.5 Strategic Overview
             15.3.6. Siemens Healthineers 
                       15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.6.2 Product Portfolio
                       15.3.6.3 SWOT Analysis
                       15.3.6.4 Financial Overview
                       15.3.6.5 Strategic Overview
             15.3.7. OraSure Technologies, Inc.
                       15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.7.2 Product Portfolio
                       15.3.7.3 SWOT Analysis
                       15.3.7.4 Financial Overview
                       15.3.7.5 Strategic Overview
             15.3.8. Chembio Diagnostic Systems
                       15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.8.2 Product Portfolio
                       15.3.8.3 SWOT Analysis
                       15.3.8.4 Financial Overview
                       15.3.8.5 Strategic Overview
             15.3.9. Danaher Corporation (Cepheid) 
                       15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.9.2 Product Portfolio
                       15.3.9.3 SWOT Analysis
                       15.3.9.4 Financial Overview
                       15.3.9.5 Strategic Overview
             15.3.10. Becton, Dickinson and Company 
                       15.3.10.1 Company Overview (HQ, Business Segments, Employee Strength)
                       15.3.10.2 Product Portfolio
                       15.3.10.3 SWOT Analysis
                       15.3.10.4 Financial Overview
                       15.3.10.5 Strategic Overview
      15.4. Key Takeaways

List of Tables

Table 01: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016-2025
Table 02: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 03: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 04: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2025
Table 05: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 06: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016-2025
Table 07: Global HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 08: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 09: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 10: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 11: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 12: Europe HIV/AIDS Diagnostic Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 13: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 14: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 15: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 16: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 17: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 18: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 19: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 20: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025
Table 21: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2025
Table 22: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2016–2025
Table 23: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2025
Table 24: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2025

List of Figures

Figure 01: Market Size, by Test Type (US$ Mn), 2016
Figure 02: Market Share, Top Trends by Product Type
Figure 03: Market Share by Region, 2016
Figure 04: Market Share Analysis by Region
Figure 05: Key Industry Developments
Figure 06: Porter’s Five Forces Analysis 
Figure 07: Global HIV/AIDS Diagnostics Market Size (US$ Mn) and Forecast, 2016–2025
Figure 08: Preventive Measures for HIV/AIDS
Figure 09: Global Market Value Share, by Product type (2016)
Figure 10: Global Market Value Share, by Test Type (2016)
Figure 11: Global Market Value Share, by End users (2016)
Figure 12: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025 Analysis
Figure 13: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits and Reagents, 2015–2025
Figure 14: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), Reagents, by Instruments, 2015–2025
Figure 15: Global HIV/AIDS Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 16: HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 17: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 18: Global HIV/AIDS Diagnostic Market Revenue, by Rapid Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global HIV/AIDS Diagnostic Market Revenue, by ELISA (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global HIV/AIDS Diagnostic Market Revenue, by Nucleic Acid Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global HIV/AIDS Diagnostic Market Revenue, by Others Test Market (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017 -2025
Figure 23: Global HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 24: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 25: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Private Diagnostic Laboratories, 2015–2025 
Figure 26: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2015–2025
Figure 27: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 28: Global HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-user, 2017-2025
Figure 29: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Region, 2016 and 2025
Figure 30: Global HIV/AIDS Diagnostics Market Attractiveness Analysis, by Region, 2017–2025
Figure 31: North America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 32: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017 -2025
Figure 33: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 34: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 35: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 36: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 38: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test type, 2017-2025
Figure 39: North America HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User, 2017-2025
Figure 40: Europe HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 41: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 42: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 43: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 44: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 45: Europe HIV/AIDS Diagnostic Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017 -2025
Figure 47: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017 -2025
Figure 48: Europe HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User
Figure 49: Asia Pacific HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 50: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 51: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 52: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 53: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 54: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 55: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product type, 2017-2025
Figure 56: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017-2025
Figure 57: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness Analysis, by End-User, 2017-2025
Figure 58: Latin America HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 60: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 61: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 62: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 63: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 64: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 65: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017- 2025
Figure 66: Latin America HIV/AIDS Diagnostics Market Attractiveness Analysis, by End Users, 2017-2025
Figure 67: Middle East & Africa HIV/AIDS Diagnostics Market Size (US$ Mn) Forecast, 2015–2025
Figure 68: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Country, 2017-2025
Figure 69: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 70: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 71: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by End-User, 2016 and 2025
Figure 72: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 73: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Product Type, 2017-2025
Figure 74: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by Test Type, 2017-2025
Figure 75: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness Analysis, by End Users, 2017- 2025
Figure 76: Global HIV/AIDS Diagnostics Market Share Analysis, by Company (2016)